In summary, our results indicate that SUSD2 expression reflects the malignant potential of GC and will serve as novel biomarker that predicts recurrence and prognosis after curative resection of GC SUSD2 may serve as a target of therapy and therefore will facilitate the development of effective therapeutic strategies. Here, SUSD2 is linked to gastric cancer.